Travanti Pharma Inc. Report issue

For profit Phase 2
Founded: Mendota MN United States (1997)
Status: Acquired by Teikoku Pharma USA, Inc. (2009)

Organization Overview

First Clinical Trial
2008
NCT00794976
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

urea (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tennis Elbow (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1